Members Trust CO Bristol Myers Squibb CO Transaction History

Members Trust CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $214,575 - $238,252	3,368 New	3,368 $215,000
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $13 - $7,684	-100 Reduced 2.75%	3,540 $252,000
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $32,315 - $35,591	-445 Reduced 10.89%	3,640 $280,000
Q1 2022 Aug 03, 2022	SELL	$61.48 - $73.72 $36,273 - $43,494	-590 Reduced 12.62%	4,085 $298,000
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $47,677 - $55,580	-889 Reduced 15.98%	4,675 $291,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $329,221 - $385,640	-5,564 Reduced 50.0%	5,564 $337,000
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $371,232 - $434,850	6,274 Added 129.25%	11,128 $658,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $85,745 - $93,376	-1,385 Reduced 22.2%	4,854 $324,000
Q1 2021 May 26, 2021	SELL	$59.34 - $66.74 $83,788 - $94,236	-1,412 Reduced 18.46%	6,239 $394,000
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $54,160 - $61,373	938 Added 13.97%	7,651 $475,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $122,957 - $136,253	2,141 Added 46.83%	6,713 $405,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $250,637 - $293,019	4,572 New	4,572 $269,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Members Trust CO, based on Form 13F filings with the SEC.

Stay updated on Members Trust CO with notifications on news.